All-trans retinoic acid modulates radiation-induced proliferation of lung fibroblasts via IL-6/IL-6R system

American Journal of Physiology - Lung Cellular and Molecular Physiology

Volumn 290, Issue 3, 2006, Pages

  Tabata, Chiharu ^a   Kubo, Hajime ^a   Tabata, Rie ^b   Wada, Manabu ^c   Sakuma, Keiichiro ^a   Ichikawa, Masataka ^a   Fujita, Shiro ^a   Mio, Tadashi ^a   Mishima, Michiaki ^a  

^a KYOTO UNIVERSITY   (Japan)

^b Hyogo Prefectural Tsukaguchi Hospital   (Japan)

^c Keihanna Hospital   (Japan)

Author keywords

Cytokine receptors; Cytokines; Interleukin 6 receptor; Lung fibrosis; Radiation pneumonitis

Indexed keywords

GLYCOPROTEIN GP 130; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; MESSENGER RNA; PROTEIN KINASE C GAMMA; RETINOIC ACID; ROTTLERIN; ANTINEOPLASTIC AGENT;

ANIMAL EXPERIMENT; ARTICLE; CELL PROLIFERATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DRUG INHIBITION; ENZYME ACTIVITY; FEMALE; HUMAN; HUMAN CELL; IRRADIATION; LUNG FIBROBLAST; LUNG FIBROSIS; MOUSE; MYELOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION; ANIMAL; C57BL MOUSE; CYTOLOGY; DRUG EFFECT; FIBROBLAST; GAMMA RADIATION; GENETICS; LUNG; METABOLISM; RADIATION EXPOSURE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL PROLIFERATION; CYTOKINE RECEPTOR GP130; FEMALE; FIBROBLASTS; GAMMA RAYS; HUMANS; INTERLEUKIN-6; LUNG; MICE; MICE, INBRED C57BL; NF-KAPPA B; RECEPTORS, INTERLEUKIN-6; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TRETINOIN;

EID: 33644938230     PISSN: 10400605     EISSN: 15221504     Source Type: Journal    
DOI: 10.1152/ajplung.00282.2005     Document Type: Article

References (49)

1. Anscher MS, Marks LB, Shafman TD, Clough R, Huang H, Tisch A, Munley M, Herndon JE II, Garst J, Crawford J, and Jirtle RL. Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol 19: 3758-3765, 2001.
2. 1 concentrations in bronchoalveolar lavage fluid associated with thoracic radiotherapy. Int J Radiat Oncol Biol Phys 58: 758-767, 2004.
3. Beetz A, Peter RU, Oppel T, Kaffenberger W, Rupec RA, Meyer M, Beuningen Van D, Kind P, and Messer G. NF-κB and AP-1 are responsible for inducibility of the IL-6 promoter by ionizing radiation in HeLa cells. Int J Radiat Biol 76: 1443-1453, 2000.
4. Brach MA, Gruss HJ, Kaisho T, Asano Y, Hirano T, and Herrmann F. Ionizing radiation induces expression of interleukin 6 by human fibroblasts involving activation of nuclear factor-kappa B. J Biol Chem 268: 8466-8472, 1993.
5. Brach MA, Hass R, Sherman ML, Gunji H, Weichselbaum R, and Kufe D. Ionizing radiation induces expression and binding activity of the nuclear factor kappa B. J Clin Invest 88: 691-695, 1991.
6. Braiman L, Alt A, Kuroki T, Ohba M, Bak A, Tennenbaum T, and Sampson SR. Insulin induces specific interaction between insulin receptor and protein kinase C delta in primary cultured skeletal muscle. Mol Endocrinol 15: 565-574, 2001.
7. Chen Y, Rubin P, Williams J, Hernady E, Smudzin T, and Okunieff P. Circulating IL-6 as a predictor of radiation pneumonitis. Int J Radiat Oncol Biol Phys 49: 641-648, 2001.
8. Chen Y, Williams J, Ding I, Hernady E, Liu W, Smudzin T, Finkelstein JN, Rubin P, and Okunieff P. Radiation pneumonitis and early circulatory cytokine markers. Semin Radiat Oncol 12: 26-33, 2002.
9. WAF1. Blood 94: 251-259, 1999.
10. Dubois C, Schlageter MH, de Gentile A, Balitrand N, Toubert ME, Krawice I, Fenaux P, Castaigne S, Najean Y, Degos L, and Chomienne C. Modulation of IL-8, IL-1 beta, and G-CSF secretion by all-trans retinoic acid in acute promyelocytic leukemia. Leukemia 8: 1750-1757, 1994.
11. Eaves CJ, Cashman JD, Kay RJ, Dougherty GJ, Otsuka T, Gaboury LA, Hogge DE, Lansdorp PM, Eaves AC, and Humphries RK. Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. II. Analysis of positive and negative regulators produced by stromal cells within the adherent layer. Blood 78: 110-117, 1991.
12. Gauldie J, Richards C, Harnish D, Lansdorp P, and Baumann H. Interferon beta 2/B-cell stimulatory factor type 2 shares identity with monocyte-derived hepatocyte-stimulating factor and regulates the major acute phase protein response in liver cells. Proc Natl Acad Sci USA 84: 7251-7255, 1987.
13. Gschwendt M, Muller HJ, Kielbassa K, Zang R, Kittstein W, Rinche G, and Marks F. Rottlerin, a novel protein kinase inhibitor. Biochem Biophys Res Commun 199: 93-98, 1994.
14. Haase MG, Klawitter A, Geyer P, Alheit H, Baumann M, Kriegel TM, Kasper M, and Baretton GB. Sustained elevation of NF-κB DNA binding activity in radiation-induced lung damage in rats. Int J Radiat Biol 79: 863-877, 2003.
15. Hallahan DE, Spriggs DR, Beckett MA, Kufe DW, and Weichselbaum RR. Increased tumor necrosis factor alpha mRNA after cellular exposure to ionizing radiation. Proc Natl Acad Sci USA 86: 10104-10107, 1989.
16. Heinrich PC, Behrmann I, Muller-Newen G, Schaper F, and Graeve L. Interleukin-6-type cytokine signalling through the gp130/Jak/STAT pathway. Biochem J 334: 297-314, 1998.
17. Hirano T, Taga T, Nakano N, Yasukawa K, Kashiwamura S, Shimizu K, Nakajima K, Pyun KH, and Kishimoto T. Purification to homogeneity and characterization of human B-cell differentiation factor (BCDF or BSFp-2). Proc Natl Acad Sci USA 82: 5490-5494, 1985.
18. Hof H, Herfarth KK, Münter M, Hoess A, Motsch J, Wannenmacher M, and Debus J. Stereotactic single-dose radiotherapy of stage I non-small-cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 56: 335-341, 2003.
19. Hsu HC, Yang K, Kharbanda S, Clinton S, Datta R, and Stone RM. All-trans retinoic acid induces monocyte growth factor receptor (c-fms) gene expression in HL-60 leukemia cells. Leukemia 7: 458-462, 1993.
20. Jain N, Zhang T, Kee WH, Li W, and Cao X. Protein kinase C delta associates with and phosphorylates Stat3 in an interleukin-6-dependent manner. J Biol Chem 274: 24392-24400, 1999.
21. Kawano M, Hirano T, Matsuda T, Taga T, Horii Y, Iwato K, Asaoku H, Tang B, Tanabe O, Tanaka H, Kuramoto A, and Kishimoto T. Autocrine generation and essential requirement of BSF-2/IL-6 for human multiple myeloma. Nature 322: 83-85, 1988.
22. Kilpatrick LE, Song YH, Rossi MW, and Korchak HM. Serine phosphorylation of p60 tumor necrosis factor receptor by PKC-delta in TNF-alpha-activated neutrophils. Am J Physiol Cell Physiol 279: C2011-C2018, 2000.
23. Klein B, Zhang XG, Jourdan M, Content J, Houssiau F, Aarden L, Piechaczyk M, and Bataille R. Paracrine rather than autocrine regulation of myeloma-cell growth and differentiation by interleukin-6. Blood 73: 517-526, 1989.
24. Levy Y, Labaume S, Colombel M, and Brouet JC. Retinoic acid modulates the in vivo and in vitro growth of IL-6 autocrine human myeloma cell lines via induction of apoptosis. Clin Exp Immunol 104: 167-172, 1996.
25. Li W, Jiang YX, Zhang J, Soon L, Flechner L, Kapoor V, Pierce JH, and Wang LH. Protein kinase C-delta is an important signaling molecule in insulin-like growth factor I receptor-mediated cell transformation. Mol Cell Biol 18: 5888-5898, 1998.
26. Lokhorst HM, Lamme T, de Smet M, Klein S, de Weger RA, van Oers R, and Bloem AC. Primary tumor cells of myeloma patients induce interleukin-6 secretion in long-term bone marrow cultures. Blood 84: 2269-2277, 1994.
27. Maeno T, Tanaka T, Sando Y, Suga T, Maeno Y, Nakagawa J, Hosono T, Sato M, Akiyama H, Kishi S, Nagai R, and Kurabayashi M. Stimulation of vascular endothelial growth factor gene transcription by all trans retinoic acid through Sp1 and Sp3 sites in human bronchioloalveolar carcinoma cells. Am J Respir Cell Mol Biol 26: 246-253, 2002.
28. Martiny-Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, and Schachtele C. Selective inhibition of protein kinase C isozymes by the Indolocarbazole Go 6976. J Biol Chem 268: 9194-9197, 1993.
29. Matikainen S, Tapiovaara H, Vaheri A, and Hurme M. Activation of interleukin-1 beta gene expression during retinoic acid-induced granulocytic differentiation of promyeloid leukemia cells. Cell Growth Differ 5: 975-982, 1994.
30. Nagata Y, Negoro Y, Aoki T, Mizowaki T, Takayama K, Kokubo M, Araki N, Mitsumori M, Sasai K, and Shibamoto Y. Clinical outcomes of 3D conformal hypofractionated single high-dose radiotherapy for one or two lung tumors using a stereotactic body frame. Int J Radiat Oncol Biol Phys 52: 1041-1046, 2002.
31. Novotny-Diermayr V, Zhang T, Gu L, and Cao X. Protein kinase C delta associates with the interleukin-6 receptor subunit glycoprotein (gp) 130 via Stat3 and enhances Stat3-gp130 interaction. J Biol Chem 277: 49134-49142, 2002.
32. Ogata A, Nishimoto N, Shima Y, Yoshizaki K, and Kishimoto T. Inhibitory effect of all-trans retinoic acid on the growth of freshly isolated myeloma cells via interference with interleukin-6 signal transduction. Blood 84: 3040-3046, 1994.
33. Pelicano L, Li F, Schindler C, and Chelbi-Alix MK. Retinoic acid enhances the expression of interferon-induced proteins: evidence for multiple mechanisms of action. Oncogene 15: 2349-2359, 1997.
34. Rube CE, Uthe D, Schmid KW, Richter KD, Wessel J, Schuck A, Willich N, and Rube C. Dose-dependent induction of transforming growth factor beta (TGF-beta) in the lung tissue of fibrosis-prone mice after thoracic irradiation. Int J Radiat Oncol Biol Phys 47: 1033-1042, 2000.
35. Schuringa JJ, Dekker LV, Vellenga E, and Kruijer W. Sequential activation of Rac-1, SEK-1/MKK-4, and protein kinase C delta is required for interleukin-6-induced STAT3 Ser-727 phosphorylation and transactivation. J Biol Chem 276: 27709-27715, 2001.
36. Schwabe M, Zhao J, and Kung Hf. Differential expression and ligand-induced modulation of the human interleukin-6 receptor on interleukin-6-responsive cells. J Biol Chem 269: 7201-7209, 1994.
37. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, and Kufe DW. Regulation of tumor necrosis factor gene expression by ionizing radiation in human myeloid leukemia cells and peripheral blood monocytes. J Clin Invest 87: 1794-1797, 1991.
38. Shibanuma M, Kuroki T, and Nose K. Inhibition by N-acetyl-L-cysteine of interleukin-6 mRNA induction and activation of NF kappa B by tumor necrosis factor alpha in a mouse fibroblastic cell line, Balb/3T3. FEBS Lett 353: 62-66, 1994.
39. Sidell N, Taga T, Hirano T, Kishimoto T, and Saxon A. Retinoic acid-induced growth inhibition of a human myeloma cell line via down-regulation of IL-6 receptors. J Immunol 146: 3809-3814, 1991.
40. Strassmann G, Jacob CO, Evans R, Beall D, and Fong M. Mechanisms of experimental cancer cachexia. Interaction between mononuclear phagocytes and colon-26 carcinoma and its relevance to IL-6-mediated cancer cachexia. J Immunol 148: 3674-3678, 1992.
41. Taetle R, Dos Santos B, Akamatsu K, Koishihara Y, and Ohsugi Y. Effects of all-trans retinoic acid and antireceptor antibodies on growth and programmed cell death of human myeloma cells. Clin Cancer Res 2: 253-259, 1996.
42. Takagi N, Mihara M, Moriya Y, Nishimoto N, Yoshizaki K, Kishimoto T, Takeda Y, and Ohsugi Y. Blockage of interleukin-6 receptor ameliorates joint disease in murine collagen-induced arthritis. Arthritis Rheum 41: 2117-2121, 1998.
43. Tkatch LS, Rubin KA, Ziegler SF, and Tweardy DJ. Modulation of human G-CSF receptor mRNA and protein in normal and leukemic myeloid cells by G-CSF and retinoic acid. J Leukoc Biol 57: 964-971, 1995.
44. Wang XJ, Taga T, Yoshida K, Saito M, Kishimoto T, and Kikutani H. gp130, the cytokine common signal-transducer of interleukin-6 cytokine family, is downregulated in T cells in vivo by interleukin-6. Blood 91: 3308-3314, 1998.
45. Witte L, Fuks Z, Haimovitz-Friedman A, Vlodavsky I, Goodman DS, and Eldor A. Effects of irradiation on the release of growth factors from cultured bovine, porcine, and human endothelial cells. Cancer Res 49: 5066-5072, 1989.
46. Woloschak GE, Chang-Liu CM, Jones PS, and Jones CA. Modulation of gene expression in Syrian hamster embryo cells following ionizing radiation. Cancer Res 50: 339-344, 1990.
47. Yokoi T, Miyawaki T, Yachie A, Kato K, Kasahara Y, and Taniguchi N. Epstein-Barr virus-immortalized B cells produce IL-6 as an autocrine growth factor. Immunology 70: 100-105, 1990.
48. Yoshizaki K, Matsuda T, Nishimoto N, Kuritani T, Taeho L, Aozasa K, Nakahata T, Kawai H, Tagoh H, and Komori T. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74: 1360-1367, 1989.
49. Zohlnhofer D, Graeve L, Rose-John S, Schooltink H, Dittrich E, and Heinrich PC. The hepatic interleukin-6 receptor. Down-regulation of the interleukin-6 binding subunit (gp80) by its ligand. FEBS Lett 306: 219-222, 1992.